HUP0300368A3 - Pharmaceutical composition for diseases due to stenotic lesions of blood vessel - Google Patents
Pharmaceutical composition for diseases due to stenotic lesions of blood vesselInfo
- Publication number
- HUP0300368A3 HUP0300368A3 HU0300368A HUP0300368A HUP0300368A3 HU P0300368 A3 HUP0300368 A3 HU P0300368A3 HU 0300368 A HU0300368 A HU 0300368A HU P0300368 A HUP0300368 A HU P0300368A HU P0300368 A3 HUP0300368 A3 HU P0300368A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical composition
- blood vessel
- diseases due
- stenotic lesions
- stenotic
- Prior art date
Links
- 210000004204 blood vessel Anatomy 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000003902 lesion Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002966 stenotic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000104344 | 2000-04-06 | ||
| PCT/JP2001/002946 WO2001076587A1 (fr) | 2000-04-06 | 2001-04-05 | Remedes aux maladies associees aux lesions stenosees de vaisseaux sanguins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0300368A2 HUP0300368A2 (hu) | 2003-07-28 |
| HUP0300368A3 true HUP0300368A3 (en) | 2004-07-28 |
Family
ID=18617901
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0300368A HUP0300368A3 (en) | 2000-04-06 | 2001-04-05 | Pharmaceutical composition for diseases due to stenotic lesions of blood vessel |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20040068015A1 (hu) |
| EP (1) | EP1275385A1 (hu) |
| JP (1) | JPWO2001076587A1 (hu) |
| KR (1) | KR20020087124A (hu) |
| CN (1) | CN1434709A (hu) |
| AU (1) | AU4683601A (hu) |
| BR (1) | BR0109889A (hu) |
| CA (1) | CA2404775A1 (hu) |
| HU (1) | HUP0300368A3 (hu) |
| MX (1) | MXPA02009839A (hu) |
| NO (1) | NO20024821L (hu) |
| RU (1) | RU2002126568A (hu) |
| TW (1) | TW575421B (hu) |
| WO (1) | WO2001076587A1 (hu) |
| ZA (1) | ZA200207974B (hu) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010137017A2 (en) | 2009-05-27 | 2010-12-02 | Yeda Research And Development Co. Ltd. | Proteasome inhibitors and uses thereof |
| AU2019215105A1 (en) * | 2018-02-01 | 2020-08-13 | Pharma Cinq, Llc | Compositions and devices for systemic delivery of uridine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843089A (en) * | 1990-12-28 | 1998-12-01 | Boston Scientific Corporation | Stent lining |
| US5516781A (en) * | 1992-01-09 | 1996-05-14 | American Home Products Corporation | Method of treating restenosis with rapamycin |
| PL205341B1 (pl) * | 1996-01-23 | 2010-04-30 | Shionogi & Co | Pochodne sulfonowanych aminokwasów i zawierające je kompozycje farmaceutyczne inhibitujące metaloproteinazę |
| EP1024134A4 (en) * | 1997-10-09 | 2003-05-14 | Ono Pharmaceutical Co | DERIVATIVES OF AMINOBUTANIC ACID |
-
2001
- 2001-04-05 US US10/240,860 patent/US20040068015A1/en not_active Abandoned
- 2001-04-05 HU HU0300368A patent/HUP0300368A3/hu unknown
- 2001-04-05 JP JP2001574105A patent/JPWO2001076587A1/ja active Pending
- 2001-04-05 KR KR1020027013277A patent/KR20020087124A/ko not_active Application Discontinuation
- 2001-04-05 AU AU46836/01A patent/AU4683601A/en not_active Abandoned
- 2001-04-05 WO PCT/JP2001/002946 patent/WO2001076587A1/ja not_active Application Discontinuation
- 2001-04-05 RU RU2002126568/15A patent/RU2002126568A/ru not_active Application Discontinuation
- 2001-04-05 MX MXPA02009839A patent/MXPA02009839A/es unknown
- 2001-04-05 CN CN01810822A patent/CN1434709A/zh active Pending
- 2001-04-05 EP EP01919785A patent/EP1275385A1/en not_active Withdrawn
- 2001-04-05 CA CA002404775A patent/CA2404775A1/en not_active Abandoned
- 2001-04-05 BR BR0109889-6A patent/BR0109889A/pt not_active Application Discontinuation
- 2001-04-06 TW TW90108250A patent/TW575421B/zh active
-
2002
- 2002-10-03 ZA ZA200207974A patent/ZA200207974B/en unknown
- 2002-10-04 NO NO20024821A patent/NO20024821L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200207974B (en) | 2004-02-10 |
| KR20020087124A (ko) | 2002-11-21 |
| WO2001076587A1 (fr) | 2001-10-18 |
| AU4683601A (en) | 2001-10-23 |
| CN1434709A (zh) | 2003-08-06 |
| TW575421B (en) | 2004-02-11 |
| RU2002126568A (ru) | 2004-03-20 |
| MXPA02009839A (es) | 2003-09-22 |
| JPWO2001076587A1 (ja) | 2004-01-08 |
| EP1275385A1 (en) | 2003-01-15 |
| CA2404775A1 (en) | 2002-10-02 |
| HUP0300368A2 (hu) | 2003-07-28 |
| NO20024821D0 (no) | 2002-10-04 |
| NO20024821L (no) | 2002-12-06 |
| BR0109889A (pt) | 2003-06-03 |
| US20040068015A1 (en) | 2004-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0301244A3 (en) | Use of rapamycin for preparation of pharmaceutical composition to treat heart and cardiovascular diseases | |
| HUP0302956A3 (en) | Thioflavin derivatives for use in diagnosis of alzheimer's disease, process for preparation of compounds and pharmaceutical compositions containing them | |
| IL188506A0 (en) | Use of an immunogen for preparation of pharmaceutical composition for treating alzheimer's disease | |
| AU6408901A (en) | Early diagnosis of conformational diseases | |
| AU3469400A (en) | Pharmaceutical compositions for treatment of diseased tissues | |
| GB0015745D0 (en) | Treatment of bone diseases | |
| HUP0400548A3 (en) | Use of combinations of iop-reducing active inoredient for preparation of pharmaceutical compositions available for treatment glaucoma | |
| HUP0203303A3 (en) | Compositions for administering taxanes orally to human patients | |
| HUP0003546A3 (en) | Compositions for administering taxanes orally to human patients | |
| HUP9904317A3 (en) | Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases | |
| HRP20020893A2 (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
| HUP0104963A3 (en) | Compositions for the treatment of skin diseases | |
| HUP0303731A3 (en) | Sulfonylguanidines and their use for preparation of pharmaceutical compositions | |
| HUP0102159A3 (en) | Pharmaceutical composition for the treatment of rumen acidosis | |
| HUP0300402A3 (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them | |
| HUP0204005A3 (en) | Novel forms of pravastatin sodium, process for their preparation and pharmaceutical compositions containing them | |
| HUP0303055A3 (en) | Polymorphs of zaleplon and methods for the preparation thereof and pharmaceutical compositions containing them | |
| HUP0300368A3 (en) | Pharmaceutical composition for diseases due to stenotic lesions of blood vessel | |
| AU9545701A (en) | Use of carp inhibitors for the treatment of heart diseases | |
| AU8879801A (en) | Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases | |
| HUP0301134A3 (en) | Use of 7-hydroxyepiandrosterone having neuroprotective activity for preparing pharmaceutical compositions | |
| HUP0204528A3 (en) | Use of de deramciclane for preparation of pharmaceutical composition available for treatment of disorders relating to serotonergic system | |
| HUP9801925A3 (en) | Use of sodium-hydrogen-exchange-inhibitors for producing pharmaceutical compositions treating diseases caused by protozoons | |
| HUP0200311A3 (en) | Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions | |
| HUP0103149A3 (en) | Pharmaceutical composition for treatment of alzheimer's disease |